Atai Life Sciences N.V. (FRA:9VC)
Germany · Delayed Price · Currency is EUR 3.293
+0.108 (3.39%)
Last updated: Jul 31, 2025
Atai Life Sciences Market Cap
Atai Life Sciences has a market cap or net worth of €760.37 million as of August 1, 2025. Its market cap has increased by 201.40% in one year.
Market Cap
760.37M
Enterprise Value
700.04M
Revenue
1.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.29
Market Cap Chart
Since June 18, 2021, Atai Life Sciences's market cap has decreased from 2.50B to 760.37M, a decrease of -69.62%. That is a compound annual growth rate of -25.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 760.37M | 252.73% |
| Dec 31, 2024 | 215.57M | 1.79% |
| Dec 29, 2023 | 211.77M | -48.71% |
| Dec 30, 2022 | 412.86M | -61.61% |
| Dec 31, 2021 | 1.08B | -57.03% |
| Jun 18, 2021 | 2.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 294.64B |
| Siemens Aktiengesellschaft | 178.07B |
| Deutsche Telekom AG | 154.90B |
| Allianz SE | 131.98B |
| Siemens Energy AG | 80.60B |
| Rheinmetall AG | 79.38B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 74.19B |
| Deutsche Bank Aktiengesellschaft | 55.92B |